Monetising daignostics
Six scalable models show how daignostics can be monetised with AI and remote healthcare, unlocking revenue and universal access.
Monetising daignostics Read More »
Finance
Insights into the economic models and investment strategies shaping the rapid expansion of daignostics.
Managing risk for profitability
Managing daignostics risk for profitability The question isn’t whether daignostics is perfect. The question is whether it will be profitable. For billions without access to healthcare, the comparison isn’t AI versus human excellence – it’s AI versus nothing. That reframes the risk calculation entirely. Table of contents Managing risk for profitability The accuracy question: comparing
Managing risk for profitability Read More »
How daignostics will be monetised
The business case for daignostics doesn’t rely on hypotheticals. Multiple financial models already exist, proven through telehealth adoption and validated by capital flows. What remains is execution – scaling proven approaches across populations that traditional healthcare economics cannot reach. The numbers are substantial. Europe’s digital health market stands at $96.7 billion in 2025, forecast to
How daignostics will be monetised Read More »
The financial case for scalable AI diagnostics
Artificial intelligence is reshaping the economics of healthcare access. The unmet need is enormous: an estimated 4.5 billion people lack full coverage for essential health services, and McKinsey forecasts up to $360 billion in annual savings for global healthcare providers through AI adoption. The commercial question is straightforward. Can AI deliver diagnostics profitably to populations
The financial case for scalable AI diagnostics Read More »